Analyst Reco. Amgen Inc. Buenos Aires S.E.

Equities

AMGN

ARDEUT110665

End-of-day quote Buenos Aires S.E. Other stock markets 03:30:00 24/06/2024 am IST			5-day change	1st Jan Change
13,942 ^ARS	+4.20%		+10.93%	+49.37%

21/06	US FDA approves Roche's drug for a chronic blood disorder	RE
14/06	Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	DJ

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating	14/06	MT
RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating	14/06	MT
HSBC Adjusts Price Target on Amgen to $356 From $322	20/05	MT
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating	13/05	MT
ANALYST RECOMMENDATIONS : UBER, Luluemon, Airbnb, Progressive...	09/05
Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170	09/05	MT
Mizuho Securities Raises Amgen's Price Target to $235 From $223	08/05	MT
North American Morning Briefing : Stock Futures -2-	06/05	DJ
UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating	03/05	MT
Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained	03/05	MT
William Blair Upgrades Amgen to Outperform From Market Perform	03/05	MT
Leerink Adjusts Price Target on Amgen to $352 From $324, Keeps Market Perform Rating	03/05	MT
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	03/05	RE
Barclays Upgrades Amgen to Equalweight From Underweight, Adjusts Price Target to $300 From $230	03/05	MT
Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating	03/05	MT
RBC Adjusts Price Target on Amgen to $328 From $332, Keeps Outperform Rating	03/05	MT
BMO Capital Adjusts Price Target on Amgen to $355 From $336, Keeps Outperform Rating	03/05	MT
Goldman Sachs Adjusts Price Target on Amgen to $350 From $359, Keeps Buy Rating	03/05	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	03/05
UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating	17/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Amgen Inc. Buenos Aires S.E.

Equities

AMGN

ARDEUT110665

Analyst Reco.

Filters